Cited by 390IL-33, ST2, and ILC PathwaysAsthma and respiratory diseasesMast cells and histamine

Enhanced innate type 2 immune response in peripheral blood from patients with asthma

Open access
Bartemes, Kathleen R., Kephart, Gail M., Fox, Stephanie J., Kita, Hirohito·2014·Journal of Allergy and Clinical Immunology

Abstract

Background In mice, group 2 innate lymphoid cells (ILC2s) likely mediate helminth immunity, inflammation, and tissue repair and remodeling. However, the involvement of ILC2s in human diseases, such as asthma, is not well understood.Objectives The goals of this study were to investigate whether peripheral blood specimens can be used to monitor innate type 2 immunity in human subjects and to examine whether ILC2s are involved in human asthma.Methods PBMCs from subjects with allergic asthma (AA), subjects with allergic rhinitis (AR), or healthy control (HC) subjects were cultured in vitro with IL-25 or IL-33. Flow cytometry and cell sorting were used to identify, isolate, and quantitate ILC2s in PBMCs.Results Human PBMCs produced IL-5 and IL-13 when stimulated with IL-33 or IL-25 in the presence of IL-2 without antigens. In addition, IL-7 or thymic stromal lymphopoietin were able to replace IL-2. The cell population with phenotypic ILC2 characteristics, lineage(-)CD127(+)CRTH2(+) cells, responded to IL-33 and produced large quantities of IL-5 and IL-13 but undetectable levels of IL-4. PBMCs from subjects with AA produced significantly larger amounts of IL-5 and IL-13 in response to IL-25 or IL-33 than from subjects with AR or HC. The prevalence of ILC2s in blood was greater in the AA group than in the AR group or the HC group.Conclusions Innate type 2 immune responses are increased in asthma but not in AR, suggesting potential differences in the immunopathogenesis of these diseases. Peripheral blood is useful for evaluating innate type 2 immunity in humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2014.06.024

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Innate lymphoid cells (ILCs) have been discovered as potential key players in pathogenesis of Th2-type diseases such as AR, CRSwNP, and asthma.

    “An interesting recent development was the discovery of innate lymphoid cells (ILCs) as potential key players in the pathogenesis of Th2-type diseases such as AR, CRSwNP, and asthma.328-330”

    From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [330]

    The Introduction reports increased ILC2s in allergic asthma and their accumulation in nasal polyps and sinus mucosa in chronic rhinosinusitis, supporting a potential role in asthma and CRSwNP. It also says increased innate type 2 responses were not observed in allergic rhinitis (AR). The Discussion suggests ILC2s may play a more prominent role in asthma than in AR, so the source does not support treating all three diseases alike. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bartemes, K. R., Kephart, G. M., Fox, S. J., & Kita, H.
Affiliations
Mayo Clinic (US)
Corresponding author
Kita, Hirohito
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2014-09
Volume
134
Issue
3
Pages
671-678.e4
ISSN
0091-6749 (ISSN-L)
OpenAlex
W1969324457
Cited by
390
References
44
Citations by year
2026: 18 · 2025: 16 · 2024: 22 · 2023: 30 · 2022: 29 · 2021: 40 · 2020: 36 · 2019: 33 · 2018: 30 · 2017: 53 · 2016: 40 · 2015: 38 · 2014: 5
FWCI
20.70
Type
journal article
Language
en
Open access
Locations
  • Journal of Allergy and Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (AI34486, HL117823)
  • Mayo Foundation for Medical Education and Research
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
Keywords
ILC2, allergic asthma, allergic rhinitis, IL-33, IL-25, IL-5, IL-13, IL-4, peripheral blood mononuclear cells, CRTH2, CD127, thymic stromal lymphopoietin, IL-7, immunopathogenesis
MeSH terms
Asthma, Blood Circulation, Cell Differentiation, Cell Separation, Cells, Cultured, Female, Flow Cytometry, Humans, Immunity, Innate, Interleukins, Lymphocytes, Male, Middle Aged, Receptors, Immunologic, Receptors, Prostaglandin, Th2 Cells, Interleukin-7 Receptor alpha Subunit, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review